Engineered PanK Enzymes for Nucleoside Analogue Synthesis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing nucleoside analogues, such as MK-8591, face challenges due to their chemical complexity, which hinders effective inhibition of HIV reverse transcriptase and subsequent treatment of AIDS.
Innovation Solution
Engineered pantothenate kinase (PanK) enzymes with specific polypeptide sequences and substitutions are developed to enhance the production of pharmaceutical compounds, particularly targeting HIV reverse transcriptase inhibition.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If standard chemical synthetic techniques are used to produce nucleoside analogues, then the production process is straightforward, but the chemical complexity of the analogues hinders effective inhibition of HIV reverse transcriptase
Solution Approach 1:
The patent employs parameter changes by modifying amino acid residues at specific positions (e.g., positions 106, 169, 218, 305 in SEQ ID NO: 60) to alter the enzymatic properties of PanK. These substitutions change the enzyme's substrate specificity, catalytic efficiency, and resistance to inhibition, thereby enabling effective production of nucleoside analogues with improved HIV reverse transcriptase inhibition while maintaining manufacturability through biochemical engineering rather than complex chemical synthesis
Solution Approach 2:
The patent replaces standard chemical synthetic techniques with an engineered biochemical system. By designing modified PanK enzymes with altered amino acid sequences, the invention substitutes complex chemical synthesis with a more controllable enzymatic pathway that can produce the same nucleoside analogues with improved efficacy and simplified manufacturing processes
2Productivity
If engineered PanK enzymes with multiple substitutions are used, then the production efficiency of nucleoside analogues is improved, but the enzyme structure becomes more complex
Solution Approach 1:
The patent applies local quality by introducing specific amino acid substitutions at key positions within the PanK enzyme structure rather than modifying the entire enzyme. The substitutions are localized to functional regions (e.g., substrate binding pockets, catalytic sites) to achieve improved productivity while minimizing overall structural complexity. This targeted approach allows the enzyme to maintain its fundamental structure while gaining enhanced catalytic properties
Solution Approach 2:
The engineered PanK enzymes represent composite structures combining wild-type PanK framework with specific mutant residues. The enzyme functions as a composite system where the base structure provides stability and general function, while the substituted amino acids contribute specialized properties for improved nucleoside analogue production efficiency
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The engineered PanK enzymes improve the production of pharmaceutical compounds, offering more effective inhibition of HIV reverse transcriptase, thereby ameliorating AIDS symptoms.
Implementation Method 1
engineered pantothenate kinase (PanK) enzymes... The engineered PanK enzymes improve the production of pharmaceutical compounds
Data Source
AI summary
The present invention provides engineered pantothenate kinase (PanK) enzymes, polypeptides having PanK activity, and polynucleotides encoding these enzymes, as well as vectors and host cells comprising these polynucleotides and polypeptides. Methods for producing PanK enzymes are also provided. The present invention further provides compositions comprising the PanK enzymes and methods of using the engineered PanK enzymes. The present invention finds particular use in the production of pharmaceutical compounds.